Skip to main content

Closed

SRZN: Surrozen, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin-573.8%

ROIC-38.0%

Financially safe

Stretched

Debt / equity-0.02×

Interest coverage0.0×

Current ratio11.91×

Surrozen, Inc.

SRZNNASDAQ Capital Market·USD·Closed

Surrozen, Inc.

SRZNNASDAQ·USD·Closed

$22.21

+6.63%

$22.21

+$1.38 (6.63%)

52W Range

51thpctl

Volume

1.86×avg

Mkt Cap

166.07MUSD

P/E

-0.5TTM

Div Yield

–ann

52W Range

51thpctl

Volume

1.86×avg

Market Cap

166.07MUSD

P/E Ratio

-0.5TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings